Terms ending in 2042
Every in-force patent on Sanofi's record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,076,539 | Injector Device In force · High confidence | Sanofi | In force | High confidence | |
| US 12,527,917 | Apparatus for Measuring Medicament Level In force · High confidence | Sanofi | In force | High confidence | |
| US 12,090,306 | Wireless Electronics Assembly for Injection Devices In force · High confidence | Sanofi | In force | High confidence | |
| US 12,024,553 | Dosage Regimens for and Compositions Including Anti-Rsv Antibodies In force · High confidence | MedImmune Limited and Sanofi Pasteur Inc. | In force | High confidence | |
| US 12,314,293 | Information System and Electronic Device In force · High confidence | Sanofi | In force | High confidence | |
| US 11,694,773 | Methods to Estimate Effectiveness of a Medical Treatment In force · High confidence | Sanofi | In force | High confidence | |
| US 12,109,395 | Device and Mixing And/Or Reconstitution Method In force · High confidence | Sagentia Ltd. | In force | High confidence | |
| US 12,344,648 | Novel IL-15 Conjugates and Uses Thereof In force · High confidence | Sanofi | In force | High confidence | |
| US 12,053,516 | Meningococcal B Recombinant Vaccine In force · High confidence | Sanofi Vaccines US Inc. | In force | High confidence | |
| US 12,239,820 | Cartridge Unit for a Drug Delivery Device In force · High confidence | Sanofi | In force | High confidence | |
| 57 more term ends in 2042 · Pro | |||||
10 of 67 patents shown. Soonest term end first, then patent number.
Pro members see all 67.
63 of these are in force and held by Sanofi.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.